List of Interesting ideas and Views:
- THE AGENTIC REVOLUTION: 12 Months That Rewrote the Rules of Business
- Report: Meta Harness – Why we need it & Players available
- Databricks Genie Ontology
- The Autonomous Enterprise Architecture for SAP and NemoClaw
- SAP Joule Studio 2.0 & SAP Business AI Platform The technical blueprint
- The Future of AI Agents – 8 Key Predictions
- Design of my Personal Agent – OpenClaw
- Internet Of Agents (IoA)
- SAP TechEd 2025 session on “Extending SAP Joule with Joule Studio”
- What should be next for AI in Enterprise level: Hear Sam Altman and Ali Ghodsi talk about it.
- Who are the winners of last 24 months for investors? Nvidia, Bitcoin, Gold, US30…
- Joule Analytical Insights & “Just Ask” Best Practices
- Michael Saylor’s Prophecy About Crypto Currency
- SAP Rise & Grow and AI Platform Technologies – Some ideas
- Statistical Consequences of Fat Tails: Real World Preasymptotics
Prediction Markets–If it is not trading what is it?
While many are only hearing about prediction markets for the first time, for near a decade they were active. It is a shame that I have not noticed them. Life is strange. For example; trading on the outcome of Britney Spear’s conservatorship and the Suez Canal obstruction! – Could this event become a contract? In order to understand the process you need to navigate first. Polymarket PredictIt Kalshi A prediction market is a...
Why does XM (Exprience Management) matter?
To understand why things happen, you need to understand the thoughts and emotions of the people involved
2019 Sıcak Konuları @CEO Gündemi
2019 sıcak konularını hızlıca bir slide’da derlemeye çalıştım. Aklımdayken burdan paylaşayım dedim 🙂 Ugur CEO Agenda 2019 by Ugur Candan from ugur candan
Living Longer – Learning from an Ultimate Question of Life
Life expectancy was driven mainly by improvements in sanitation, housing, and education, causing a steady decline in early and mid-life mortality, which was chiefly due to infections. This trend continued with the development of vaccines and then antibiotics. By the latter half of the twentieth century, there was little room for further reduction in early and mid-life mortality.